Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein PropagationOmid Tavassoly, Edward A. Fon|Neurotherapeutics|2021Cited by 26